EUDA Research Development from 2010 to 2025

EUDAW Stock   0.12  0.01  9.09%   
EUDA Health Research Development yearly trend continues to be fairly stable with very little volatility. Research Development will likely drop to about 14.7 K in 2025. During the period from 2010 to 2025, EUDA Health Research Development regression line of quarterly data had mean square error of 1.6 B and geometric mean of  88,184. View All Fundamentals
 
Research Development  
First Reported
2010-12-31
Previous Quarter
15.5 K
Current Value
14.7 K
Quarterly Volatility
62.8 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check EUDA Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among EUDA Health's main balance sheet or income statement drivers, such as Tax Provision of 0.0, Depreciation And Amortization of 183.4 K or Interest Expense of 19.9 K, as well as many indicators such as Price To Sales Ratio of 11.84, Dividend Yield of 0.0 or Days Sales Outstanding of 25.73. EUDA financial statements analysis is a perfect complement when working with EUDA Health Valuation or Volatility modules.
  
Check out the analysis of EUDA Health Correlation against competitors.

Latest EUDA Health's Research Development Growth Pattern

Below is the plot of the Research Development of EUDA Health Holdings over the last few years. It is EUDA Health's Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in EUDA Health's overall financial position and show how it may be relating to other accounts over time.
Research Development10 Years Trend
Slightly volatile
   Research Development   
       Timeline  

EUDA Research Development Regression Statistics

Arithmetic Mean120,750
Geometric Mean88,184
Coefficient Of Variation51.99
Mean Deviation52,298
Median158,011
Standard Deviation62,775
Sample Variance3.9B
Range143.3K
R-Value(0.78)
Mean Square Error1.6B
R-Squared0.61
Significance0.0003
Slope(10,323)
Total Sum of Squares59.1B

EUDA Research Development History

202514.7 K
202415.5 K
202217.2 K
2021129.3 K

About EUDA Health Financial Statements

EUDA Health investors use historical fundamental indicators, such as EUDA Health's Research Development, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in EUDA Health. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Research Development15.5 K14.7 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for EUDA Stock Analysis

When running EUDA Health's price analysis, check to measure EUDA Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EUDA Health is operating at the current time. Most of EUDA Health's value examination focuses on studying past and present price action to predict the probability of EUDA Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EUDA Health's price. Additionally, you may evaluate how the addition of EUDA Health to your portfolios can decrease your overall portfolio volatility.